On August 4th, TRIUMF welcomed Dr. Paul Schaffer to the laboratory as Deputy Head of the growing Nuclear Medicine Division. Dr. Schaffer comes to TRIUMF with a wealth of experience and expertise in nuclear medicine imaging and therapy and was most recently Lead Scientist for organic radiochemistry with GE Global Research in New York.
"We're thrilled that Dr. Schaffer has joined our team of leading researchers and scientists," said Dr. Nigel Lockyer, TRIUMF Director. "His extensive knowledge and experience in nuclear medicine and radiochemistry (the field of medical isotopes) will continue to keep TRIUMF at the forefront of innovation. It's another example of TRIUMF's ability to attract the world's best scientists to conduct research here in Canada."
Dr. Schaffer has a Ph.D. in Chemistry from McMaster University and is recognized as a technical leader for multiple efforts related to radiopharmaceutical development. He has worked extensively with medical isotopes such as Technetium-99m and Fluorine-18. Aside from his duties as Deputy Head, Dr. Schaffer will be responsible for managing the new research and development component of the Nuclear Medicine Division as TRIUMF pursues a global-leadership position in the field as part of its five-year plan. The position manages a research program aimed at exploiting the science and technology capabilities at TRIUMF with an emphasis on the development and characterization of new radiotracers.
"I'm pleased to be coming home to Canada to join TRIUMF at one of the most pivotal times in the industry," says Dr. Schaffer. "TRIUMF is a long-standing Canadian research institution with world-leading science and technology and I'm excited to be part of the future of this laboratory."
-- Meghan Magee, Communications Assistant
Based on TRIUMF News Release: Top Nuclear Chemist Joins TRIUMF from the United States